{"brief_title": "Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients", "brief_summary": "The purpose of this study is to determine the effect of conversion from calcineurin inhibitor to sirolimus based therapy on renal function.", "condition": ["Renal Transplantation"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["Sirolimus", "tacrolimus", "Cyclosporine A"], "description": ["Sirolimus, Cyclosporine A & Tacrolimus are concentration controlled"], "arm_group_label": ["A", "B", "A", "B", "A", "B"], "criteria": "Inclusion Criteria: - Age greater than or equal to 13 years. - Receiving CsA or tacrolimus from the time of transplantation or within 2 weeks thereafter - Patients with a functioning allograft and a Nankivell GFR greater than or equal to 20 mL/min, within 2 weeks before randomization Exclusion Criteria: - Biopsy-confirmed acute rejection within 12 weeks before randomization, that was determined to require antirejection treatment - Patients in whom kidney-pancreas or other multiple organ transplants have been performed", "gender": "All", "minimum_age": "13 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Recipients", "mesh_term": ["Tacrolimus", "Cyclosporine", "Cyclosporins", "Sirolimus", "Everolimus", "Calcineurin Inhibitors"], "id": "NCT00038948"}